Pulmonary alveolar proteinosis (PAP) is characterized by accumulation of lipoproteinaceous material in the terminal airways. Whole lung lavage (WLL) remains the gold standard treatment but may be particularly challenging in cases of severe hypoxemia. We present a 3-step strategy that was used in a patient with PAP-associated refractory hypoxemia and that combined venovenous extracorporeal membrane oxygenation (vvECMO), double-lumen orotracheal intubation, and bilateral multisegmental sequential lavage (MSL). The procedure was well tolerated and permitted weaning from the ventilator
This report demonstrates the results following massive simultaneous lavage of both lungs in two brot...
BACKGROUND: New therapies have emerged in the treatment of pulmonary alveolar proteinosis (PAP) and,...
ABSTRACT: Pulmonary Alveolar Proteinosis (PAP) is a rare syndrome characterized by pulmonary surfact...
Pulmonary Alveolar Proteinosis (PAP) is a rare disease, 3.2-6.7 cases per million. It is caused by P...
Pulmonary alveolar proteinosis (PAP) is a rare disorder in which lipoproteinaceous material is depos...
Background. Pulmonary alveolar proteinosis is a rare disorder characterized by a large accumulation ...
Abstract Background Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by acc...
Background: Pulmonary alveolar proteinosis (PAP) is a rare disease in children, characterized by int...
Abstract: Pulmonary alveolar proteinosis is a rare condition characterized by the accumulation of li...
Pulmonary alveolar proteinosis is a rare condition characterized by the accumulation of lipoproteina...
New therapies have emerged in the treatment of pulmonary alveolar proteinosis (PAP) and, therefore, ...
The current mainstay of treatment for pulmonary alveolar proteinosis (PAP ) is whole-lung lavage. Th...
Alveolar proteinosis can be primary or secondary. The secondary alveolar proteinosis was observed in...
International audiencePAP is an ultra-rare disease in which surfactant components, that impair gas e...
Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease that appears after the accumulation o...
This report demonstrates the results following massive simultaneous lavage of both lungs in two brot...
BACKGROUND: New therapies have emerged in the treatment of pulmonary alveolar proteinosis (PAP) and,...
ABSTRACT: Pulmonary Alveolar Proteinosis (PAP) is a rare syndrome characterized by pulmonary surfact...
Pulmonary Alveolar Proteinosis (PAP) is a rare disease, 3.2-6.7 cases per million. It is caused by P...
Pulmonary alveolar proteinosis (PAP) is a rare disorder in which lipoproteinaceous material is depos...
Background. Pulmonary alveolar proteinosis is a rare disorder characterized by a large accumulation ...
Abstract Background Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by acc...
Background: Pulmonary alveolar proteinosis (PAP) is a rare disease in children, characterized by int...
Abstract: Pulmonary alveolar proteinosis is a rare condition characterized by the accumulation of li...
Pulmonary alveolar proteinosis is a rare condition characterized by the accumulation of lipoproteina...
New therapies have emerged in the treatment of pulmonary alveolar proteinosis (PAP) and, therefore, ...
The current mainstay of treatment for pulmonary alveolar proteinosis (PAP ) is whole-lung lavage. Th...
Alveolar proteinosis can be primary or secondary. The secondary alveolar proteinosis was observed in...
International audiencePAP is an ultra-rare disease in which surfactant components, that impair gas e...
Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease that appears after the accumulation o...
This report demonstrates the results following massive simultaneous lavage of both lungs in two brot...
BACKGROUND: New therapies have emerged in the treatment of pulmonary alveolar proteinosis (PAP) and,...
ABSTRACT: Pulmonary Alveolar Proteinosis (PAP) is a rare syndrome characterized by pulmonary surfact...